Literature DB >> 23286292

New insights in research about acute ischemic myocardial injury and inflammation.

Anne Vincent1, Benoit Lattuca, Nolwenn Merlet, Catherine Sportouch-Dukhan, Stephanie Barrère-Lemaire.   

Abstract

Recognition that inflammation may contribute to the pathogenesis of various cardiac diseases has naturally led to the evaluation of the therapeutic potential of a range of anti-inflammatory approaches. Unfortunately, results in most settings have been disappointing. The majority of novel approaches fail despite promising preclinical data, partly attributable to off-target effects. The purpose of this review, focused on inflammation following acute myocardial ischemia, is to give a brief overview of the new insights regarding research on pro-inflammatory signaling cascades that could be targeted for cardioprotective therapeutic developments.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23286292     DOI: 10.2174/1871523011312010007

Source DB:  PubMed          Journal:  Antiinflamm Antiallergy Agents Med Chem        ISSN: 1871-5230


  6 in total

1.  Effect of dexmedetomidine on myocardial ischemia-reperfusion injury.

Authors:  Shoulin Chen; Fuzhou Hua; Jun Lu; Yu Jiang; Yanhua Tang; Lei Tao; Bing Zou; Qinghua Wu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Diosgenin Protects Rats from Myocardial Inflammatory Injury Induced by Ischemia-Reperfusion.

Authors:  Hong-Wei Wang; Hua-Jin Liu; Hua Cao; Zeng-Yong Qiao; Ya-Wei Xu
Journal:  Med Sci Monit       Date:  2018-01-12

3.  Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation.

Authors:  Yaru Huang; Xiaotong Sun; Zhaodong Juan; Rui Zhang; Ruoguo Wang; Shuqi Meng; Jiajia Zhou; Yan Li; Keyou Xu; Keliang Xie
Journal:  BMC Anesthesiol       Date:  2021-04-06       Impact factor: 2.217

Review 4.  Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury.

Authors:  Carlota Fernandez Rico; Karidia Konate; Emilie Josse; Joël Nargeot; Stéphanie Barrère-Lemaire; Prisca Boisguérin
Journal:  Front Cardiovasc Med       Date:  2022-02-17

Review 5.  Protective Effect and Mechanism of Traditional Chinese Medicine on Myocardial Ischemia Reperfusion Injury.

Authors:  Kuo Liu; Demin Liu; Wei Cui
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-31       Impact factor: 2.629

6.  Hypercholesterolemia attenuates cardioprotection of ischemic preconditioning and postconditioning with α7 nicotinic acetylcholine receptor agonist by enhancing inflammation and inhibiting the PI3K/Akt/eNOS pathway.

Authors:  Chao Wen; Fu-Shan Xue; Yu-Hui Wang; Jin-Hua Jin; Xu Liao
Journal:  Exp Ther Med       Date:  2022-03-22       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.